DBV Technologies Investor Relations Material
Latest events
Q4 2023
DBV Technologies
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from DBV Technologies S.A.
Access all reports
DBV Technologies, S.A. is a clinical-stage biopharmaceutical company engaged in the research and development of epicutaneous immunotherapy (EPI) products to treat cancer and dermatology. The company's EPI technology platform includes monoclonal antibodies, passive transport devices using microelectrode arrays, and a wide variety of fully human anti-cancer antibodies
Latest articles
Bill Gates: The Man Who Put a Computer in Every Home
Explore the life of Bill Gates, from co-founding Microsoft to global philanthropy, and his lasting impact on the world.
2 May 2024
The Lego Story: Building a Business Brick by Brick
A detailed account of the most important milestones in the Lego Group's history, as well as an explanation of the philosophy guiding the company
2 May 2024
Kevin Plank and the Rise of Under Armour
Dive into the story of Under Armour and its founder Kevin Plank, highlighting both successes and mistakes.
30 Apr 2024
Ticker symbol
Country
🇫🇷 France